Esteban Masuda

2018

In 2018, Esteban Masuda earned a total compensation of $1.3M as Executive Vice President, Research at Rigel Pharmaceuticals, a 104% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$227,552
Option Awards$719,270
Salary$350,080
Other$3,336
Total$1,300,238

Masuda received $719.3K in option awards, accounting for 55% of the total pay in 2018.

Masuda also received $227.6K in non-equity incentive plan, $350.1K in salary and $3.3K in other compensation.

Rankings

In 2018, Esteban Masuda's compensation ranked 7,883rd out of 14,244 executives tracked by ExecPay. In other words, Masuda earned more than 44.7% of executives.

ClassificationRankingPercentile
All
7,883
out of 14,244
45th
Division
Manufacturing
3,081
out of 5,765
47th
Major group
Chemicals And Allied Products
1,154
out of 2,128
46th
Industry group
Drugs
971
out of 1,817
47th
Industry
Pharmaceutical Preparations
754
out of 1,391
46th
Source: SEC filing on April 1, 2020.

Masuda's colleagues

We found five more compensation records of executives who worked with Esteban Masuda at Rigel Pharmaceuticals in 2018.

2018

Raul Rodriguez

Rigel Pharmaceuticals

Chief Executive Officer

2018

Dolly Vance

Rigel Pharmaceuticals

General Counsel

2018

Anne-Marie Duliege

Rigel Pharmaceuticals

Chief Medical Officer

2018

Eldon Mayer

Rigel Pharmaceuticals

Executive Vice President, Chief Commercial Officer

2018

Dean Schorno

Rigel Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like